美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
70954-857-10	70954-857	HUMAN PRESCRIPTION DRUG	Dapagliflozin	Dapagliflozin	TABLET, FILM COATED	ORAL	20260513	N/A	ANDA	ANDA211156	ANI Pharmaceuticals, Inc.	DAPAGLIFLOZIN	10 mg/1	30 TABLET, FILM COATED in 1 BOTTLE (70954-857-10)
71921-420-09	71921-420	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN	Dapagliflozin	TABLET	ORAL	20260406	N/A	ANDA	ANDA211156	Florida Pharmaceutical Products, LLC	DAPAGLIFLOZIN	5 mg/1	90 TABLET in 1 BOTTLE (71921-420-09)
71921-420-33	71921-420	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN	Dapagliflozin	TABLET	ORAL	20260406	N/A	ANDA	ANDA211156	Florida Pharmaceutical Products, LLC	DAPAGLIFLOZIN	5 mg/1	30 TABLET in 1 BOTTLE (71921-420-33)
71921-420-50	71921-420	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN	Dapagliflozin	TABLET	ORAL	20260406	N/A	ANDA	ANDA211156	Florida Pharmaceutical Products, LLC	DAPAGLIFLOZIN	5 mg/1	500 TABLET in 1 BOTTLE (71921-420-50)
71921-421-09	71921-421	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN	Dapagliflozin	TABLET	ORAL	20260406	N/A	ANDA	ANDA211156	Florida Pharmaceutical Products, LLC	DAPAGLIFLOZIN	10 mg/1	90 TABLET in 1 BOTTLE (71921-421-09)
71921-421-33	71921-421	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN	Dapagliflozin	TABLET	ORAL	20260406	N/A	ANDA	ANDA211156	Florida Pharmaceutical Products, LLC	DAPAGLIFLOZIN	10 mg/1	30 TABLET in 1 BOTTLE (71921-421-33)
71921-421-50	71921-421	HUMAN PRESCRIPTION DRUG	DAPAGLIFLOZIN	Dapagliflozin	TABLET	ORAL	20260406	N/A	ANDA	ANDA211156	Florida Pharmaceutical Products, LLC	DAPAGLIFLOZIN	10 mg/1	500 TABLET in 1 BOTTLE (71921-421-50)
70954-856-10	70954-856	HUMAN PRESCRIPTION DRUG	Dapagliflozin	Dapagliflozin	TABLET, FILM COATED	ORAL	20260513	N/A	ANDA	ANDA211156	ANI Pharmaceuticals, Inc.	DAPAGLIFLOZIN	5 mg/1	30 TABLET, FILM COATED in 1 BOTTLE (70954-856-10)